“Deucravacitinib in Moderate to Severe Plaque Psoriasis: Comorbidities and Use of Prior and Concomitant Medication in Patients Enrolled in the Phase 3 POETYK PSO-1 and PSO-2 Trials”. 2024. SKIN The Journal of Cutaneous Medicine 8 (6): s428. https://doi.org/10.25251/skin.8.supp.428.